SOMERSET, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell Microcap® Index, effective at the open of U.S. markets on June 30, 2025, as part of the Russell indexes' annual reconstitution based on market capitalization, public float, and related criteria. The inclusion underscores growing re ...

SOMERSET, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the "Company"), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has surpassed the accelerated filer threshold with a public float of $85.1 million as of the market close on June 30, 2025. This achievement triggers a new compliance benchmark under SEC regulations—specifically, the inclusion of an auditor attestation of the C ...

SOMERSET, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that its current independent registered public accounting firm may resign if an ICFR auditor attestation of the Company’s Internal Control over Financial Reporting (“ICFR”) under Section 404(b) of the Sarbanes-Oxley Act is required for fiscal year 2025. Our audit firm ...

© CareCloud, Inc. 2025 DRIVING NEXT-GEN HEALTHCARE WITH GENERATIVE AI SOLUTIONS Nasdaq Global Market: CCLD, CCLDO Investor Presentation May 2025 A healthcare technology company with 25 years of experience, delivering AI-driven, end-to-end solutions that power real- world clinical and financial transformation. Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of o ...

Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that its Co-Chief Executive Officers have been invited to participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” presented by Maxim Group LLC. The Healthcare IT Panel, featuring CareCloud, will take place on Tuesday, June 3, 202 ...

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected three board members and approved executive compensation and the appointment of an accounting firm [1][2][3] - The re-elected board members include Anne Busquet, Bill Korn, and Lawrence Sharnak, all of whom have extensive experience in executive roles [2] - The shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Company Overview - CareCloud is a leader in healthcare technology solutions, providing services that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4] - The Company serves over 40,000 providers, helping them reduce administrative burdens and operating costs while improving patient care [4]

Financial Performance - For the three months ended March 31, 2025, net revenue was $27,632,000, an increase of 6.4% from $25,962,000 in the same period of 2024[161] - Adjusted EBITDA for the same period was $5,595,000, up 51.8% from $3,687,000 in 2024[161] - GAAP net income for Q1 2025 was $1,948,000 compared to a loss of $241,000 in Q1 2024[161] - The adjusted operating margin improved to 8.5% in Q1 2025 from 2.3% in Q1 2024[161] - Non-GAAP adjusted net income for Q1 2025 was $2,290,000, compared to $220,000 in Q1 2024[164] - The GAAP operating margin for Q1 2025 was 7.3%, significantly higher than 0.5% in Q1 2024[161] - Non-GAAP adjusted earnings per share for Q1 2025 was $0.05, compared to $0.01 in Q1 2024[164] - Net income for the three months ended March 31, 2025, was $1.96 million, compared to a net loss of $0.23 million in the same period of 2024[179] - The company recorded net income of $7.9 million for fiscal year 2024, a significant improvement from a net loss of $48.7 million in fiscal year 2023[195] Revenue Composition - Revenue for the three months ended March 31, 2025, was $27.6 million, an increase of $1.7 million or 6% from $25.9 million in the same period of 2024[180] - Technology-enabled business solutions accounted for approximately 64% of total revenue for the three months ended March 31, 2025[167] Expenses - Direct operating costs increased by $287,000 or 2% to $15.5 million for the three months ended March 31, 2025, compared to $15.2 million in 2024[182] - Selling and marketing expenses decreased by $639,000 or 36% to $1.1 million for the three months ended March 31, 2025[183] - General and administrative expenses increased by $611,000 or 16% to $4.3 million for the three months ended March 31, 2025[184] - Research and development expenses increased by $322,000 or 35% to $1.2 million for the three months ended March 31, 2025[185] Cash Flow and Capital Expenditures - As of March 31, 2025, the company had total cash of $6.8 million and net working capital of $11.7 million[194] - Net cash provided by operating activities increased to $5.1 million for the three months ended March 31, 2025, up 26% from $4.1 million in the same period of 2024[199] - Net cash used in investing activities decreased to $1.5 million in Q1 2025 from $1.9 million in Q1 2024, reflecting a 19% reduction[201] - Net cash used in financing activities increased to $1.9 million in Q1 2025, compared to $1.4 million in Q1 2024, representing a 41% increase[202] - Capital expenditures for Q1 2025 were $624,000, up from $298,000 in Q1 2024, primarily for computer equipment and leasehold improvements[201] - Software development costs capitalized were $846,000 in Q1 2025, down from $1.6 million in Q1 2024[201] Operational Insights - The company served approximately 40,000 providers as of March 31, 2025, maintaining the same level as in 2024[166] - The company has approximately 290 experienced health industry experts in the U.S. and a specialized offshore workforce of about 3,400[154] - Offshore operations in Pakistan and Sri Lanka accounted for approximately 17% and 15% of total expenses for Q1 2025 and 2024, respectively[156] Financial Strategy and Outlook - Management expects to continue enhancing liquidity and financial position over the next twelve months[196] - The company maintained a revolving line of credit with an unused borrowing base of $10 million as of March 31, 2025[198] - The company has been able to monitor and mitigate the impact of inflation through pricing strategies and productivity improvements[197] - The interest rate on the company's line of credit is based on the prime rate, which has shown slight fluctuations in 2023 and 2024[197]

CareCloud (CCLD) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Company Participants Kristen Rothe - Corporate Counsel and Privacy OfficerStephen Snyder - Co- CEOHadi Chaudhry - Co - CEONorman Roth - Interim CFO and Corporate ControllerMahmud Haq - Founder & Executive Chairman Conference Call Participants Allen Klee - MD, Equity Research Analyst, TMTMichael Kim - Senior Analyst Operator Ladies and gentlemen, greetings, and welcome to the CareCloud, Inc. First Quarter twenty twenty five Earnings Conference C ...

CareCloud (CCLD) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Ladies and gentlemen, greetings, and welcome to the CareCloud, Inc. First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Kristen Rotti, Corporate Counsel. Please go ahead. Speaker1 Good morning, everyone. W ...

RESULTS NASDAQ GLOBAL MARKET: CCLD, CCLDO A healthcare technology company with 25 years of experience, delivering AI-driven, end-to-end solutions that power real-world clinical and financial transformation. © CareCloud, Inc. 2025 This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by ...